Log in

NASDAQ:IRTCIrhythm Technologies Stock Price, Forecast & News

-2.22 (-1.22 %)
(As of 08/13/2020 04:00 PM ET)
Today's Range
Now: $179.53
50-Day Range
MA: $130.15
52-Week Range
Now: $179.53
Volume458,300 shs
Average Volume402,985 shs
Market Capitalization$4.92 billion
P/E RatioN/A
Dividend YieldN/A
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. Its Zio XT monitor, a single-use, wire-free, and wearable patch-based biosensor, records patient's heartbeats and ECG data. The company was founded in 2006 and is headquartered in San Francisco, California.
Read More
Irhythm Technologies logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.21 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolNASDAQ:IRTC



Sales & Book Value

Annual Sales$214.55 million
Book Value$5.09 per share


Net Income$-54,570,000.00


Market Cap$4.92 billion
Next Earnings Date11/3/2020 (Estimated)
-2.22 (-1.22 %)
(As of 08/13/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IRTC News and Ratings via Email

Sign-up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Irhythm Technologies (NASDAQ:IRTC) Frequently Asked Questions

How has Irhythm Technologies' stock price been impacted by COVID-19 (Coronavirus)?

Irhythm Technologies' stock was trading at $85.54 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, IRTC stock has increased by 109.9% and is now trading at $179.53.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Irhythm Technologies?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Irhythm Technologies in the last year. There are currently 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Irhythm Technologies

When is Irhythm Technologies' next earnings date?

Irhythm Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Irhythm Technologies

How were Irhythm Technologies' earnings last quarter?

Irhythm Technologies Inc (NASDAQ:IRTC) posted its earnings results on Thursday, August, 6th. The company reported ($0.75) earnings per share for the quarter, topping the consensus estimate of ($0.84) by $0.09. The company had revenue of $50.88 million for the quarter, compared to analyst estimates of $42.18 million. Irhythm Technologies had a negative net margin of 28.50% and a negative return on equity of 48.70%. The firm's revenue for the quarter was down 3.0% on a year-over-year basis. During the same period in the prior year, the business earned ($0.43) earnings per share.
View Irhythm Technologies' earnings history

What price target have analysts set for IRTC?

10 analysts have issued 1 year price targets for Irhythm Technologies' shares. Their forecasts range from $130.00 to $200.00. On average, they expect Irhythm Technologies' share price to reach $166.38 in the next twelve months. This suggests that the stock has a possible downside of 7.3%.
View analysts' price targets for Irhythm Technologies

Has Irhythm Technologies been receiving favorable news coverage?

Media coverage about IRTC stock has trended negative on Friday, InfoTrie reports. The research group identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Irhythm Technologies earned a coverage optimism score of -2.4 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days.
View the latest news about Irhythm Technologies

Are investors shorting Irhythm Technologies?

Irhythm Technologies saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 3,720,000 shares, a decrease of 12.7% from the April 30th total of 4,260,000 shares. Based on an average trading volume of 429,000 shares, the short-interest ratio is currently 8.7 days.
View Irhythm Technologies' Short Interest

Who are some of Irhythm Technologies' key competitors?

What other stocks do shareholders of Irhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Irhythm Technologies investors own include NVIDIA (NVDA), Cisco Systems (CSCO), Alibaba Group (BABA), salesforce.com (CRM), Teladoc Health (TDOC), DexCom (DXCM), Micron Technology (MU), Paypal (PYPL), Shopify (SHOP) and Veeva Systems (VEEV).

Who are Irhythm Technologies' key executives?

Irhythm Technologies' management team includes the following people:
  • Mr. Kevin M. King, Pres, CEO & Director (Age 63)
  • Mr. Matthew C. Garrett, Chief Financial Officer (Age 51)
  • Mr. David A. Vort, Exec. VP of Sales (Age 53)
  • Dr. Derrick Sung, Exec. VP of Strategy & Corp. Devel. (Age 46)
  • Mr. Karim Karti, Chief Operating Officer (Age 50)

When did Irhythm Technologies IPO?

(IRTC) raised $76 million in an IPO on Thursday, October 20th 2016. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is Irhythm Technologies' stock symbol?

Irhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

Who are Irhythm Technologies' major shareholders?

Irhythm Technologies' stock is owned by a number of retail and institutional investors. Top institutional investors include William Blair Investment Management LLC (5.27%), Macquarie Group Ltd. (3.22%), TimesSquare Capital Management LLC (2.27%), New York State Common Retirement Fund (2.02%), Victory Capital Management Inc. (1.87%) and FMR LLC (1.31%). Company insiders that own Irhythm Technologies stock include Bruce G Bodaken, David A Vort, Derrick Sung, Kevin M King, Matthew C Garrett, Merz Cathleen Noel Bairey, Ralph Snyderman and Raymond W Scott.
View institutional ownership trends for Irhythm Technologies

Which major investors are selling Irhythm Technologies stock?

IRTC stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Macquarie Group Ltd., TimesSquare Capital Management LLC, Bellevue Group AG, Great Lakes Advisors LLC, Principal Financial Group Inc., Prudential Financial Inc., and EAM Investors LLC. Company insiders that have sold Irhythm Technologies company stock in the last year include David A Vort, Kevin M King, Matthew C Garrett, Ralph Snyderman, and Raymond W Scott.
View insider buying and selling activity for Irhythm Technologies

Which major investors are buying Irhythm Technologies stock?

IRTC stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Blair William & Co. IL, Columbus Circle Investors, Federated Hermes Inc., First Trust Advisors LP, Victory Capital Management Inc., Marshall Wace North America L.P., and NN Investment Partners Holdings N.V..
View insider buying and selling activity for Irhythm Technologies

How do I buy shares of Irhythm Technologies?

Shares of IRTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Irhythm Technologies' stock price today?

One share of IRTC stock can currently be purchased for approximately $179.53.

How big of a company is Irhythm Technologies?

Irhythm Technologies has a market capitalization of $4.92 billion and generates $214.55 million in revenue each year. The company earns $-54,570,000.00 in net income (profit) each year or ($2.16) on an earnings per share basis. Irhythm Technologies employs 748 workers across the globe.

What is Irhythm Technologies' official website?

The official website for Irhythm Technologies is www.irhythmtech.com.

How can I contact Irhythm Technologies?

Irhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The company can be reached via phone at 415-632-5700 or via email at [email protected]

This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.